15 0

Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease

Title
Effect of a 150 mg dose of rifabutin on serum itraconazole levels in patients with coexisting chronic pulmonary aspergillosis and Mycobacterium avium complex lung disease
Author
이현
Keywords
Chronic pulmonary aspergillosis; Nontuberculous mycobacteria; Mycobacterium avium complex; Itraconazole; Rifabutin
Issue Date
2017-05
Publisher
ELSEVIER SCIENCE BV
Citation
JOURNAL OF INFECTION AND CHEMOTHERAPY, v. 23, no. 9, page. 658-660
Abstract
Patients with coexisting chronic pulmonary aspergillosis and nontuberculous mycobacterial lung disease may undergo treatment with both the antifungal itraconazole and the antimycobacterial rifamycin. However, rifamycins interact with itraconazole. We examined the effects of a 150 mg dose of rifabutin on serum itraconazole levels and found significantly lower levels in 28 patients receiving itraconazole with rifabutin (median, 0.65 mu g/ml) compared with 65 patients receiving itraconazole alone (median 3.45 mu g/ml, P < 0.001). One-third of patients receiving itraconazole and rifabutin reached the therapeutic range of serum itraconazole concentration. Therapeutic drug monitoring is strongly recommended during concomitant use of rifabutin and itraconazole. (C) 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
URI
https://www.jiac-j.com/article/S1341-321X(17)30031-4/fulltexthttp://repository.hanyang.ac.kr/handle/20.500.11754/114087
ISSN
1341-321X; 1437-7780
DOI
10.1016/j.jiac.2017.02.004
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE